Perspectives on the therapeutic potential of short-chain fatty acid receptors
- Authors
- Kim, Sunhong; Kim, Jeong-Hoon; Park, Bi Oh; Kwak, Young Shin
- Issue Date
- 31-3월-2014
- Publisher
- KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY
- Keywords
- GPR41; GPR43; Inflammation; Obesity; SCFA
- Citation
- BMB REPORTS, v.47, no.3, pp.173 - 178
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- BMB REPORTS
- Volume
- 47
- Number
- 3
- Start Page
- 173
- End Page
- 178
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/98973
- DOI
- 10.5483/BMBRep.2014.47.3.272
- ISSN
- 1976-6696
- Abstract
- There is rapidly growing interest in the human microbiome because of its implication in metabolic disorders and inflammatory diseases. Consequently, understanding the biology of short chain fatty acids and their receptors has become very important for identifying novel therapeutic avenues. GPR41 and GPR43 have been recognized as the cognate receptors for SCFAs and their roles in metabolism and inflammation have drawn much attention in recent years. GPR43 is highly expressed on immune cells and has been suggested to play a role in inflammatory diseases such as inflammatory bowel disease. Both GPR41 and GPR43 have been implicated in diabetes and obesity via the regulation of adipose tissue and gastrointestinal hormones. So far, many studies have provided contradictory results, and therefore further research is required to validate these receptors as drug targets. We will also discuss the synthetic modulators of GPR41 and GPR43 that are critical to understanding the functions of these receptors.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > Department of Pharmaceutical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.